Shamik J. Parikh, Chief Medical Officer at Humacyte, Inc. ($HUMA), made one open market purchase of company shares in the last 365 days, totaling $11,625. His most recent buy occurred on April 10, 2025. This ranks him 4,176th among nearly 5,000 insiders in our database by purchase value, well below the average of 1.5 million dollars across about 3.3 transactions per insider. Parikh reported no open market sales during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 16, 2025 | Humacyte, Inc. | $HUMA | Parikh Shamik J | Chief Medical Officer | A | Common Stock | 311100 | $0.00 | 318,600.0000 | 187,271,321 | 4148.00% | 0.17% |
| April 10, 2025 | Humacyte, Inc. | $HUMA | Parikh Shamik J | Chief Medical Officer | P | Common Stock | 7500 | $1.55 | 7,500.0000 | 155,118,816 | 9999.99% | 0.00% |
| Jan. 21, 2025 | Humacyte, Inc. | $HUMA | Parikh Shamik J | Chief Medical Officer | A | Stock Options (right to buy) | 283101 | $0.00 | 283,101.0000 | 0 | 9999.99% | 0.00% |
| Dec. 8, 2023 | Humacyte, Inc. | $HUMA | Parikh Shamik J | Chief Medical Officer | A | Stock Options (right to buy) | 283000 | $0.00 | 283,000.0000 | 0 | 9999.99% | 0.00% |